Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 250Lymphoma 137Leukemia 124Burkitt Lymphoma 90Leukemia, Myeloid, Acute 69Lymphoma, Non-Hodgkin 65Lymphoma, Large B-Cell, Diffuse 59Myelodysplastic Syndromes 54Leukemia, Lymphocytic, Chronic, B-Cell 49Lymphoma, Mantle-Cell 47Hodgkin Disease 47Lymphoma, Follicular 45Leukemia, Myeloid, Accelerated Phase 39Multiple Myeloma 34Lymphoma, Large-Cell, Immunoblastic 33Leukemia, Myeloid, Chronic-Phase 33Recurrence 32Blast Crisis 32Lymphoma, B-Cell, Marginal Zone 31Congenital Abnormalities 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Myeloproliferative Disorders 30Leukemia, Biphenotypic, Acute 30Graft vs Host Disease 30Leukemia, Myelomonocytic, Chronic 28Dendritic Cell Sarcoma, Interdigitating 25Neoplasms, Plasma Cell 22Primary Myelofibrosis 21Lymphoma, T-Cell, Cutaneous 20Lymphoma, Large-Cell, Anaplastic 20

Interventions

thymoglobulin 1sargramostim 1ruxolitinib 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Rituximab 1Observation 1Mycophenolic Acid 1Monatide (IMS 3015) 1Methotrexate 1Melphalan 1Granulocyte-Macrophage Colony-Stimulating Factor 1Cyclophosphamide 1Clofarabine 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Methotrexate × Lymphoid × Clear all
NCT04314219 2025-03-13

PTCy-PMAT

King Faisal Specialist Hospital & Research Center

Phase 3 Recruiting
264 enrolled
LymphoidOther hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡